Effects of synthetic salmon calcitonin therapy in children with osteogenesis imperfecta

I Rebelo, Luis Pereira-da-Silva, J C Blanco, Maria Elisa Monteiro, N C Ferreira

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

A total of four children with osteogenesis imperfecta, three with type I and one with type III forms of the disease, were treated with synthetic salmon calcitonin for 18-24 months. The annual fracture rate was decreased during calcitonin therapy compared with the period preceding it. No patient presented a marked inflexion in linear growth and a transient improvement was even noticed in two cases.

Original languageEnglish
Pages (from-to)401-5
Number of pages5
JournalJournal of molecular medicine (Berlin, Germany)
Volume17
Issue number4
DOIs
Publication statusPublished - Jul 1989

Keywords

  • Age Determination by Skeleton
  • Body Height
  • Bone Development
  • Calcitonin
  • Child
  • Child, Preschool
  • Female
  • Fractures, Bone
  • Humans
  • Male
  • Osteogenesis Imperfecta
  • Journal Article

Fingerprint Dive into the research topics of 'Effects of synthetic salmon calcitonin therapy in children with osteogenesis imperfecta'. Together they form a unique fingerprint.

  • Cite this